- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 15.3267 ↓ -1.49%
[as on 13 February, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan and its peers as on 13 February, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| quant Healthcare Fund - Growth Option - Direct Plan | -1.6% | -1.49% | 2.02% | -0.09% | -4.66% | 3.91% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -3.44% | -1.05% | 0.6% | -1.55% | -4.72% | 1.29% | 13.92% | 16.69% | 16.2% | 16.86% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.92% | -0.96% | -0.17% | -0.93% | -1.11% | 10.24% | 14.69% | 12.18% | 14.56% | 14.93% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -0.71% | -1.01% | 1.53% | -0.77% | -3.47% | 3.79% | 25.54% | 16.87% | 21.41% | 13.46% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -1.43% | -1.21% | -0.35% | 1.76% | -1.33% | 8.93% | 22.39% | 21.1% | 21.08% | 18.32% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 5.59% | -1.19% | 1.43% | 5.81% | 6.15% | 30.1% | 35.14% | 29.88% | 23.35% | 18.01% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 32.34% | -4.87% |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|
| Returns | 5.25% | 5.45% | 2.45% | -2.43% | -0.14% | 0.25% | 1.27% | -0.5% | -1.78% | -5.07% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -7.93% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 78.95% |
6.21% (Arbitrage: 0.00%) |
0.00% |
0.00% |
-3.65% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sequent Scientific Limited | SEQUENT (INE807F01027) | Pharmaceuticals & Biotechnology | 8.26% |
| Zydus Wellness Ltd | ZYDUSWELL (INE768C01028) | Food Products | 7.97% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 7.89% |
| SMS Pharmaceuticals Limited | SMSPHARMA (INE812G01025) | Pharmaceuticals & Biotechnology | 6.53% |
| Pfizer Ltd | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 6.51% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 6.45% |
| ANTHEM BIOSCIENCES LIMITED | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 6.17% |
| Adani Enterprises Limited | ADANIENT (INE423A01024) | Metals & Minerals Trading | 6.14% |
| Alivus Life Sciences | ALIVUS (INE03Q201024) | Pharmaceuticals & Biotechnology | 5.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 3.58% |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 3.40% |
| Concord Biotech Limited | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 3.14% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.91% |
| Godrej Properties Limited | GODREJPROP (INE484J01027) | Realty | 2.80% |
| Gland Pharma Limited | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.41% |
Debt
| Name | Rating | Weight % |
|---|
| 91 Days Treasury Bill 18-Dec-2025 | N.A. | 1.81% |
| 91 Days Treasury Bill 20-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 28-Nov-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 04-Dec-2025 | N.A. | 0.78% |
| 91 Days Treasury Bill 02-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 15-Jan-2026 | N.A. | 0.77% |
| 91 Days Treasury Bill 23-Jan-2026 | N.A. | 0.51% |
Portfolio data is as on date 31 October, 2025
NAV history
quant Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 13 February, 2026 | 15.3267 |
| 12 February, 2026 | 15.5588 |
| 11 February, 2026 | 15.4867 |
| 10 February, 2026 | 15.2893 |
| 9 February, 2026 | 15.2537 |
| 6 February, 2026 | 15.023 |
| 5 February, 2026 | 15.0242 |
| 4 February, 2026 | 15.1176 |
| 3 February, 2026 | 15.1336 |
| 2 February, 2026 | 14.7868 |
| 30 January, 2026 | 14.9626 |
| 29 January, 2026 | 14.7581 |
| 28 January, 2026 | 14.7625 |
| 27 January, 2026 | 14.6224 |
| 23 January, 2026 | 14.6304 |
| 22 January, 2026 | 14.8391 |
| 21 January, 2026 | 14.5926 |
| 20 January, 2026 | 14.7092 |
| 19 January, 2026 | 14.9927 |
| 16 January, 2026 | 15.22 |
| 14 January, 2026 | 15.3458 |
| 13 January, 2026 | 15.34 |
| 12 January, 2026 | 15.3951 |
| 9 January, 2026 | 15.4624 |
| 8 January, 2026 | 15.6131 |
| 7 January, 2026 | 15.9139 |
| 6 January, 2026 | 15.9235 |
| 5 January, 2026 | 15.7846 |
| 2 January, 2026 | 15.7633 |
| 1 January, 2026 | 15.576 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of quant Healthcare Fund - Growth Option - Direct Plan is 15.3267 as on 13 February, 2026.
What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan are -1.6% as on 13 February, 2026.
What are 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan are 3.91% as on 13 February, 2026.